(Q36116972)

12 August 2017

Lessons from type I interferons in ulcerative colitis (English)

1 reference

12 August 2017

1

Arthur Kaser

1 reference

12 August 2017

Richard S Blumberg

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

25 January 2011

1 reference

12 August 2017

1 reference

12 August 2017

60

1 reference

12 August 2017

4

1 reference

12 August 2017

430-431

1 reference

Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592161

Inflammatory bowel disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592161

NKT cells in mucosal immunity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592161

Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592161

A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592161

Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592161

Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592161

Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592161

Expression of Murine CD1 on Gastrointestinal Epithelium

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592161

Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592161

Induction of remission by interferon-alpha in patients with chronic active ulcerative colitis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592161

Differential regulation of interleukin 4 and interleukin 13 production by interferon alpha

23 September 2018

1 reference

12 December 2020

Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitis

1 reference

12 December 2020

Interferon-beta-1a for the treatment of steroid-refractory ulcerative colitis: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Human recombinant interferon-beta influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.2010.229138

1 reference

release_mdcgvosuk5aibbpkfgedpprxhq

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mdcgvosuk5aibbpkfgedpprxhq

24 November 2022

mapped directly with Wikidata item

1 reference

12 August 2017

PubMed publication ID

21266724

1 reference